Dianthus Therapeutics, Inc. (DNTH)
(Delayed Data from NSDQ)
$28.97 USD
+0.88 (3.13%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $28.88 -0.09 (-0.31%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Dianthus Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -43.56 | -76.46 | -71.14 | -74.94 | -76.77 |
Depreciation/Amortization & Depletion | -1.07 | 1.93 | 2.02 | 1.98 | 1.84 |
Net Change from Assets/Liabilities | 4.86 | -2.70 | -1.53 | -1.19 | 8.83 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.90 | 10.15 | 11.11 | 10.12 | 8.99 |
Net Cash From Operating Activities | -36.86 | -67.09 | -59.53 | -64.02 | -57.10 |
Property & Equipment | -0.11 | -0.31 | -1.26 | -0.40 | -3.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 20.36 | -9.50 | 44.69 | -10.24 | 4.59 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 20.25 | -9.81 | 43.43 | -10.64 | 1.53 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.01 | 3.02 | 3.50 | 68.04 | 62.90 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 133.57 | -0.14 | 86.10 | -0.30 | -0.60 |
Net Cash from Financing Activities | 133.57 | 2.88 | 89.60 | 67.74 | 62.30 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 116.97 | -74.02 | 73.50 | -6.92 | 6.73 |
Cash at Beginning of Period | 15.43 | 133.43 | 59.93 | 66.85 | 60.13 |
Cash at End of Period | 132.39 | 59.41 | 133.43 | 59.93 | 66.85 |
Diluted Net EPS | -8.45 | -20.64 | -20.64 | -27.36 | -33.12 |
Fiscal Year End for Dianthus Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -13.75 | -43.56 | -32.99 | -32.45 |
Depreciation/Amortization & Depletion | NA | -0.41 | -1.07 | -0.64 | 0.42 |
Net Change from Assets/Liabilities | NA | -2.82 | 4.86 | 6.46 | -19.57 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 2.04 | 2.90 | 2.17 | 9.46 |
Net Cash From Operating Activities | NA | -14.94 | -36.86 | -25.01 | -42.14 |
Property & Equipment | NA | -0.03 | -0.11 | -0.10 | 1.84 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -5.48 | 20.36 | 28.59 | 40.23 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 3.30 |
Net Cash from Investing Activities | NA | -5.51 | 20.25 | 28.49 | 45.37 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.27 | 0.01 | 0.01 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 217.58 | 133.57 | 138.43 | 0.00 |
Net Cash from Financing Activities | NA | 217.85 | 133.57 | 138.44 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 197.40 | 116.97 | 141.92 | 3.23 |
Cash at Beginning of Period | NA | 132.39 | 15.43 | 15.43 | 59.41 |
Cash at End of Period | NA | 329.79 | 132.39 | 157.35 | 62.63 |
Diluted Net EPS | NA | -0.54 | 3.81 | -3.78 | -0.80 |